Université de Genève-ko ikertzaileekin lankidetzan egindako argitalpenak (77)

2024

  1. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6722-6739

  2. Blood-based multivariate methylation risk score for cognitive impairment and dementia

    Alzheimer's and Dementia, Vol. 20, Núm. 10, pp. 6682-6698

  3. Optimising Clinical Epidemiology in Disease Outbreaks: Analysis of ISARIC-WHO COVID-19 Case Report Form Utilisation

    Epidemiologia, Vol. 5, Núm. 3, pp. 557-580

  4. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease

    Computers in Biology and Medicine, Vol. 176

2023

  1. Executive Summary of the Second International Guidelines for the Diagnosis and Management of Pediatric Acute Respiratory Distress Syndrome (PALICC-2)

    Pediatric Critical Care Medicine, Vol. 24, Núm. 2, pp. 143-168

  2. Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease

    Alzheimer's and Dementia, Vol. 19, Núm. 8, pp. 3350-3364

  3. Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey

    World Journal of Emergency Surgery, Vol. 18

  4. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

    HPB, Vol. 25, Núm. 9, pp. 985-999

2022

  1. Functional eigenvector centrality dynamics are related to amyloid deposition in preclinical Alzheimer’s Disease

    Alzheimer's and Dementia

  2. Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset

    Frontiers in Aging Neuroscience, Vol. 14

  3. Multi-omic alterations of the SWI/SNF complex define a clinical subgroup in lung adenocarcinoma

    Clinical Epigenetics, Vol. 14, Núm. 1

  4. Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks

    Frontiers in Aging Neuroscience, Vol. 14

2021

  1. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study

    Digestive and Liver Disease, Vol. 53, Núm. 5, pp. 639-645

  2. Disease-related cortical thinning in presymptomatic granulin mutation carriers

    NeuroImage: Clinical, Vol. 29

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies

    Frontiers in Aging Neuroscience, Vol. 13

  5. Replication study of plasma proteins relating to Alzheimer's pathology

    Alzheimer's and Dementia, Vol. 17, Núm. 9, pp. 1452-1464

  6. Sex-specific metabolic pathways were associated with alzheimer’s disease (Ad) endophenotypes in the european medical information framework for ad multimodal biomarker discovery cohort

    Biomedicines, Vol. 9, Núm. 11

  7. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels

    Alzheimer's and Dementia, Vol. 17, Núm. 10, pp. 1628-1640

  8. Tratamientos Psicológicos Empíricamente Apoyados Para Adultos: Una Revisión Selectiva

    Psicothema, Vol. 33, Núm. 2, pp. 188-197